DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Omniscan (Gadodiamide) - Oedema Peripheral - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Oedema Peripheral (92)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Omniscan (Gadodiamide) where reactions include oedema peripheral. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 92   Next >>

Possible Omniscan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 15 ml, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Prohance
    Dosage: unk unk, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Gadolinium IN Unspecified Drug
    Indication: Osteomyelitis

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk unk, once
    Start date: 2005-01-25
    End date: 2005-01-25

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-15
    End date: 2002-11-15

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Diabetic Foot

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-01-14
    End date: 2005-01-14

Magnevist
    Dosage: 19 ml, once
    Start date: 2004-07-16
    End date: 2004-07-16

Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix



Possible Omniscan side effects in 49 year old male

Reported by a lawyer from United States on 2012-08-02

Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased

Drug(s) suspected as cause:
Omniscan

Multihance
    Indication: Product Used FOR Unknown Indication

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-05-19
    End date: 2006-05-19

Magnevist
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-10-13
    End date: 2006-10-13

Omniscan
    Dosage: 50 ml omniscan+co2
    Indication: Fistulogram
    Start date: 2006-08-04
    End date: 2006-08-04

Gadolinium IN Unspecified Drug
    Start date: 2004-05-19
    End date: 2004-05-19

Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-05
    End date: 2006-08-05

Prohance
    Indication: Computerised Tomogram Head
    Start date: 2004-05-19
    End date: 2004-05-19

Optimark
    Indication: Product Used FOR Unknown Indication

Magnevist
    Dosage: 20 ml, unk
    Start date: 2006-10-17
    End date: 2006-10-17

Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine



Possible Omniscan side effects in 49 year old female

Reported by a consumer/non-health professional from United States on 2012-07-18

Patient: 49 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Skin Wrinkling, Joint Stiffness, Oedema Peripheral, Melanocytic Naevus, Fibrosis, Arthrofibrosis, General Physical Health Deterioration, Hypoaesthesia, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Paraesthesia, Skin Tightness, Scar, Abasia, Pain, Joint Contracture, Skin Hyperpigmentation, Muscle Tightness, Tendon Pain, Joint Range of Motion Decreased, Skin Lesion, Musculoskeletal Stiffness, Injury, Joint Ankylosis, Extremity Contracture, Myocardial Fibrosis, Dyspnoea, Rash Papular, Musculoskeletal Pain, Skin Disorder, Muscular Weakness, Rash Macular, Pulmonary Fibrosis, Arthralgia, Gait Disturbance, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Start date: 2004-05-20
    End date: 2004-05-20

Magnevist
    Start date: 1999-11-09
    End date: 1999-11-09

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-01-30
    End date: 2005-01-30

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1997-04-30
    End date: 1997-04-30

Magnevist
    Start date: 1998-12-31
    End date: 1998-12-31

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1996-10-30
    End date: 1996-10-30

Magnevist
    Start date: 2002-01-30
    End date: 2002-01-30

Magnevist
    Start date: 2005-01-30
    End date: 2005-01-30

Omniscan
    Start date: 2005-03-20
    End date: 2005-03-20

Magnevist
    Start date: 1997-11-17
    End date: 1997-11-17

Magnevist
    Dosage: 9.7 ml, once
    Start date: 2003-03-20
    End date: 2003-03-20

Omniscan
    Dosage: unk

Magnevist
    Start date: 2000-11-08
    End date: 2000-11-08

Other drugs received by patient: Thyroid Therapy; Ferrous Sulfate TAB; Miacalcin; Cytoxan; Oxandrin; Folic Acid; Procardia; Synthroid; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Advair Diskus 100 / 50; Zemplar; Aranesp; Aleve; Prograf; Epogen; Exforge; Activase; Celebrex; Zestril; Renagel; Metoprolol Succinate; Amigen; Prempro; Rocaltrol; Spironolactone; Demadex; Sensipar; Myfortic; Prednisone; Clonidine; Amlodipine Besylate



Possible Omniscan side effects in 54 year old male

Reported by a lawyer from United States on 2012-07-17

Patient: 54 year old male

Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Muscle Rigidity, Neuropathic Ulcer, Erythema, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Arthralgia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-12-12
    End date: 2000-12-12

Omniscan
    Indication: Arthralgia

Omniscan
    Indication: Sepsis

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-11-29

Other drugs received by patient: Lansoprazole; Atacand HCT; Vitamin E; Verapamil HCL; Minoxidil; Misoprostol; Lorazepam; Amiodarone HCL; Humulin R; Phoslo; Vitamin D; Epoetin Alfa; Cytotec; Calcium Acetate; Cefazolin Sodium



Possible Omniscan side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient: 58 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Deformity, Skin Plaque, Skin Tightness, Gait Disturbance, Skin Fibrosis, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Other drugs received by patient: Sensipar; Ativan; Lisinopril; Loperamide; Folic Acid; Tylenol W / Codeine NO. 3; Magnesium Oxide; Plavix; Epogen; Calcijex; Zosyn; Ambien; Vitamin K1; Clonidine; Albumin (Human); Roxanol; Velcade; Adenosine; Aspirin; Dexamethasone; Acetaminophen; Compazine; Dilaudid; Foltx; Diflucan; Vancomycin; Potassium Chloride; Bactrim DS; Ciprofloxacin HCL; Hydroxyzine; Acyclovir; Mucomyst; Biaxin; Metoprolol Tartrate; Atarax; Cyclophosphamide; Norco; Neurontin; Digoxin; Ativan; Prevacid; Dexamethasone; Zoloft; Vitamin K1; Ocean; Senokot; Neupogen; Bicitra; Allopurinol; Pravachol; Levaquin; Phoslo; Gentamicin; Nephrocaps; Adriamycin PFS; Simethicone; Zemplar; Plendil; Midodrine Hydrochloride; Renaphro; Renagel; Ativan; Oxacillin; Etoposide; Reglan; Reglan; Compazine; Warfarin Sodium; Prograf



Possible Omniscan side effects in 51 year old female

Reported by a lawyer from United States on 2012-07-09

Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)

Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Fistulogram

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-01-11
    End date: 2001-01-11

Optimark
    Indication: Venogram

Multihance
    Indication: Venogram

Magnevist
    Indication: Arteriovenous Fistula Operation
    Start date: 2006-11-28
    End date: 2006-11-28

Prohance
    Indication: Venogram

Prohance
    Indication: Fistulogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk, once
    Indication: Venous Pressure Increased
    Start date: 2004-12-09
    End date: 2004-12-09

Magnevist
    Indication: Dialysis Efficacy Test
    Start date: 2006-09-26
    End date: 2006-09-26

Magnevist
    Indication: Dialysis Device Insertion

Omniscan
    Indication: Fistulogram

Optimark
    Indication: Fistulogram

Omniscan
    Indication: Venogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl



Possible Omniscan side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: 54 year old male

Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-11-29

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-12-12
    End date: 2000-12-12

Optimark

Magnevist

Omniscan

Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec



Possible Omniscan side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-28

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Pruritus, Pain, Quality of Life Decreased, Muscular Weakness, Orthostatic Hypotension, DRY Skin, Stasis Dermatitis, Nephrogenic Systemic Fibrosis, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Mobility Decreased

Drug(s) suspected as cause:
Optimark
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist

Prohance
    Indication: Angiogram

Magnevist
    Indication: Angiogram

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Multihance
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1998-05-18
    End date: 1998-05-18

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Pepcid; Meclizine; Prednisone TAB; Diovan; Plavix; Nexium; Flomax; Warfarin Sodium; Covera-HS; Norvasc; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Coumadin; Epogen; Monopril; Cytoxan; Accupril; Aspirin; Sensipar; Novolin [insulin]; Hydralazine Hydrochloride; Ancef; Acetaminophen; Kayexalate; Humulin [insulin Human Injection, Isophane]; Norvasc; Phoslo; Catapres; Prevacid; Renvela; Lasix; Amiodarone Hydrochloride; Ascorbic Acid; Fish OIL; Sodium Polystyrene Sulfonate; Procrit; Zaroxolyn; Diuril; Darvocet; Neurontin; Renagel; Clonidine; Levothyroxine; Demadex; Potassium Chloride; Verapamil; Percocet; Lopressor; Lipitor



Possible Omniscan side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Deformity, Skin Plaque, Skin Tightness, Scar, Skin Fibrosis, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Other drugs received by patient: Bicitra; Foltx; Plavix; Dexamethasone; Acetaminophen; Adriamycin PFS; Compazine; Dilaudid; Pravachol; Phoslo; Vitamin K1; Etoposide; Reglan; Hydroxyzine; Plendil; Neupogen; Acyclovir; Digoxin; Mucomyst; Renagel; Calcijex; Levaquin; Simethicone; Renaphro; Sensipar; Biaxin; Dexamethasone; Zosyn; Ciprofloxacin; Ocean; Loperamide; Senokot; Clonidine; Albumin (Human); Diflucan; Magnesium Oxide; Potassium Chloride; Gentamicin; Ambien; Compazine; Velcade; Adenosine; Ativan; Lisinopril; Epogen; Oxacillin; Reglan; Zemplar; Roxanol; Allopurinol; Tylenol W / Codeine NO. 3; Ativan; Zoloft; Nephrocaps; Vitamin K1; Cyclophosphamide; Norco; Midodrine Hydrochloride; Warfarin Sodium; Prograf; Folic Acid; Ativan; Aspirin; Prevacid; Metoprolol Tartrate; Vancomycin; Bactrim DS; Atarax; Neurontin



Possible Omniscan side effects in 58 year old female

Reported by a consumer/non-health professional from United States on 2012-06-22

Patient: 58 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Scab, Skin Burning Sensation, Skin Hyperpigmentation, Joint Stiffness, Anhedonia, Oedema Peripheral, Skin Swelling, Peau D'orange, Pain in Extremity, Muscular Weakness, Skin Disorder, Skin Induration, Livedo Reticularis, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Rash Macular, Anxiety, Mobility Decreased, Scar, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Dosage: 20 ml, unk
    Indication: Imaging Procedure
    Start date: 2003-12-20

Optimark
    Indication: Imaging Procedure

Multihance
    Indication: Imaging Procedure

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-05-26
    End date: 2005-05-26

Prohance
    Indication: Imaging Procedure

Magnevist
    Dosage: 15 ml, unk
    Indication: Angiogram
    Start date: 2006-05-30

Omniscan
    Indication: Imaging Procedure

Other drugs received by patient: Klonopin; Calcitriol; Norvasc; Zemplar; Epogen; Folbee; Immunosuppressive Agents; Sensipar; Plavix; Colchicine; Renagel; Robaxin; Synthroid; Levothyroxine Sodium; Phoslo; Immunosuppressive Agents; Corticosteroids; Hormones and Related Agents; Coumadin; Gabapentin; Antithrombotic Agents; Steroid Antibacterials; Midodrine Hydrochloride; Aspirin; Neurontin; Iron Supplement; Nephrocaps



Possible Omniscan side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20

Patient: 59 year old male

Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Post Thrombotic Syndrome, Skin Discolouration, Induration, Oedema Peripheral, Fibrosis

Drug(s) suspected as cause:
Magnevist

Omniscan

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram Peripheral
    Start date: 2003-10-24
    End date: 2003-10-24

Optimark

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2003-07-17
    End date: 2003-07-17

Other drugs received by patient: Verapamil; Lasix; Coumadin; Clonidine; Epogen; Minoxidil; Albuterol; Calcitriol; Lanoxin; Renagel; Sensipar; Glyburide; Flovent; Insulin; Iron Sulfatethiamin Compound TAB



Possible Omniscan side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-18

Patient: 59 year old male

Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Post Thrombotic Syndrome, Oedema Peripheral, Induration, Fibrosis

Drug(s) suspected as cause:
Magnevist

Omniscan

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram Peripheral
    Start date: 2003-10-24
    End date: 2003-10-24

Optimark

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2003-07-17
    End date: 2003-07-17

Other drugs received by patient: Albuterol; Minoxidil; Renagel; Insulin; Calcitriol; Lanoxin; Verapamil; Lasix; Epogen; Sensipar; Flovent; Coumadin; Glyburide; Clonidine; Iron Sulfatethiamin Compound TAB



Possible Omniscan side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: 54 year old male

Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Magnevist

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-12-12
    End date: 2000-12-12

Optimark

Omniscan



Possible Omniscan side effects in 14 year old male

Reported by a physician from Japan on 2012-06-08

Patient: 14 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Pruritus, Hyperkeratosis, Hyperthermia, Joint Contracture, Pyrexia, Scleroderma, Erythema, Oedema Peripheral, White Blood Cell Count Increased, Pain in Extremity, Rash Papular, Muscle Contracture, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Collagen Disorder, Hypoproteinaemia, Grip Strength Decreased, Inflammation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-12-28
    End date: 2006-12-28

Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Start date: 2007-01-12
    End date: 2007-01-12

Omniscan
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Glaucoma
    Start date: 2006-09-04
    End date: 2006-09-04

Magnevist
    Dosage: 10 ml (daily dose), once, intravenous
    Start date: 2004-12-17
    End date: 2004-12-17

Magnevist
    Dosage: 10 ml (daily dose), once, intravenous
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-24
    End date: 2004-07-24

Other drugs received by patient: Calcium Carbonate; Calcium Carbonate; Dexamethasone; Allopurinol; Amlodipine; Ferrous Citrate



Possible Omniscan side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Musculoskeletal Stiffness, Fibrosis, Cellulitis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Rash, Deformity, Skin Tightness, Skin Plaque, Scar, Mobility Decreased, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Other drugs received by patient: Ativan; Biaxin; Acetaminophen; Ciprofloxacin; Nephrocaps; Cyclophosphamide; Etoposide; Neupogen; Neurontin; Warfarin Sodium; Phoslo; Loperamide; Hydroxyzine; Acyclovir; Zoloft; Vitamin K1; Dilaudid; Albumin (Human); Midodrine Hydrochloride; Foltx; Digoxin; Pravachol; Dexamethasone; Epogen; Gentamicin; Ambien; Clonidine; Bicitra; Mucomyst; Magnesium Oxide; Calcijex; Zosyn; Vitamin K1; Adriamycin PFS; Ocean; Reglan; Compazine; Roxanol; Velcade; Allopurinol; Adenosine; Sensipar; Diflucan; Renagel; Ativan; Ativan; Prevacid; Bactrim DS; Simethicone; Norco; Prograf; Tylenol W / Codeine NO. 3; Dexamethasone; Reglan; Plendil; Renaphro; Folic Acid; Aspirin; Plavix; Lisinopril; Metoprolol Tartrate; Levaquin; Vancomycin; Potassium Chloride; Atarax; Oxacillin; Zemplar; Compazine; Senokot



Possible Omniscan side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01

Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)

Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Skin Hyperpigmentation, Scleroderma, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Rash Papular, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Sclerodactylia, Skin Tightness, Macule, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-13
    End date: 1999-10-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2007-03-21
    End date: 2007-03-21

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-11-18
    End date: 2008-11-18

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-28
    End date: 1999-10-28

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-01-14
    End date: 2006-01-14

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1999-09-20
    End date: 1999-09-20

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Fistulogram
    Start date: 1999-10-08
    End date: 1999-10-08

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-02-04
    End date: 2006-02-04

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-03-19
    End date: 2008-03-19

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-09-27
    End date: 1999-09-27

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-08-13
    End date: 2008-08-13

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Hydrocodone Bitartrate + Acetaminophen; Phoslo; Calcium Acetate; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Renvela



Possible Omniscan side effects in 51 year old female

Reported by a lawyer from United States on 2012-05-31

Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)

Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Joint Stiffness, Skin Fissures, Dermatitis, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Skin Haemorrhage, Injury, Pain in Extremity, Motor Dysfunction, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Sclerodactylia, Burning Sensation, Anxiety, Emotional Distress, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Omniscan
    Indication: Venogram

Optimark
    Indication: Venogram

Magnevist
    Dosage: unk, once
    Indication: Venous Pressure Increased
    Start date: 2004-12-09
    End date: 2004-12-09

Magnevist
    Indication: Arteriovenous Fistula Operation
    Start date: 2006-11-28
    End date: 2006-11-28

Magnevist
    Indication: Dialysis Device Insertion

Multihance
    Indication: Fistulogram

Prohance
    Indication: Fistulogram

Magnevist
    Indication: Dialysis Efficacy Test
    Start date: 2006-09-26
    End date: 2006-09-26

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Fistulogram

Prohance
    Indication: Venogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-01-11
    End date: 2001-01-11

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Fistulogram

Multihance
    Indication: Venogram

Other drugs received by patient: Levothroid; Atenolol; Vicodin; Immune Globulin NOS; Tramadol HCL; Protonix; Pravachol; Sensipar; Sensipar; Imodium; Immune Globulin NOS; Benadryl; Fosrenol; Nitroglycerin; Corticosteroids; Calcium Carbonate; Renagel; Phoslo; Immune Globulin NOS; Immune Globulin NOS; Loperamide; Protonix; Nephro-Vite [vitamins Nos]; Allopurinol; Allopurinol; Cyclosporine; Acetaminophen; Benadryl; Coumadin; Epoetin NOS; Vitamin B12; Immune Globulin NOS; Acetaminophen; Ureacin; Omeprazole; Amiodarone HCL; Procardia XL; Prilosec; Nifedipine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Metoclopramide; Levothroid; Coumadin; Coumadin; Calcium Carbonate; Plendil; Acetaminophen; Acetaminophen; Acetaminophen; Benadryl; PEG-3350 and Electrolytes; Cardizem; Prednisone TAB; Atenolol; Reglan; Renagel; Epogen; Pravastatin; Metoprolol Tartrate



Possible Omniscan side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Fatigue, Anhedonia, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Extremity Contracture, Peau D'orange, Pain in Extremity, Excoriation, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Scar, Skin Fibrosis, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Renal
    Start date: 2005-08-25
    End date: 2005-08-25

Omniscan
    Dosage: unk, once
    Indication: Angiogram Peripheral
    Start date: 2005-08-30
    End date: 2005-08-30

Omniscan
    Dosage: unk, once
    Start date: 2005-09-28
    End date: 2005-09-29

Omniscan
    Dosage: unk, once
    Start date: 2005-11-03
    End date: 2005-11-03

Omniscan
    Dosage: unk, once
    Start date: 2005-10-03
    End date: 2005-10-03

Optimark
    Dosage: 19 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-04-20
    End date: 2005-04-20

Omniscan
    Dosage: unk

Omniscan
    Dosage: unk, once
    Start date: 2005-10-01
    End date: 2005-10-01

Omniscan
    Dosage: unk, once
    Start date: 2005-10-18
    End date: 2005-10-18

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-17
    End date: 2006-03-17

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-08
    End date: 2005-09-08

Omniscan
    Dosage: unk, once
    Start date: 2005-09-06
    End date: 2005-09-06

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Indication: Venogram Renal
    Start date: 2005-09-01
    End date: 2005-09-01

Omniscan
    Dosage: unk, once
    Start date: 2005-10-21
    End date: 2005-10-21

Optimark
    Dosage: 19 ml, once
    Start date: 2005-07-05
    End date: 2005-07-05

Other drugs received by patient: Viagra; Oxycodone Hydrochloride; Lisinopril; Mirapex; Sodium Citrate; Prednisone TAB; Norvasc; Zaroxolyn; Lasix; Compazine; Aspirin; Folic Acid; Spiriva; Calcitriol; Ativan; Cytoxan; Acetaminophen; Pentamidine Isethionate; Albuterol; Calcitonin Salmon; Phoslo; Lexapro; Pravachol; Labetalol HCL; MS Contin; Lopressor; Thiamine; Trazodone HCL; Protonix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Kayexalate; Darbepoetin Alfa; Wellbutrin; Normodyne; Coumadin; Flagyl; Heparin; Magnesium Oxide; Fosamax



Possible Omniscan side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25

Patient: 62 year old male, weighing 124.0 kg (272.8 pounds)

Reactions: Pruritus, Hyperkeratosis, Pain, Erythema, Rash Pruritic, Skin Ulcer, Skin Lesion, Oedema Peripheral, Skin Atrophy, Pain in Extremity, Pain of Skin, Skin Disorder, Rash, Hypoaesthesia, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Plaque, Burning Sensation, Emotional Distress, Anxiety, Exfoliative Rash, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-01-17
    End date: 2006-01-17

Omniscan
    Dosage: 40 ml, then 50 ml
    Indication: Angiogram
    Start date: 2004-11-09
    End date: 2004-11-09

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Gabapentin; Renagel; Hydrochlorothiazide; Dalteparin Sodium; Magnesium; Epogen; Carvedilol; Atenolol; Lyrica; Calcium; Benicar; Folic Acid; Simvastatin; Hydralazine HCL; Aranesp; Mirtazapine; Codeine Sulfate; Norvasc; Darvocet; Renagel; Metoprolol; Furosemide; Renagel; Doxazosin Mesylate



Possible Omniscan side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25

Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Excoriation, Muscle Contracture, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Hypoaesthesia, Skin Hypopigmentation, DRY Skin, Skin Induration, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Skin Fibrosis, Scar

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Start date: 2005-10-18
    End date: 2005-10-18

Omniscan
    Dosage: unk, once
    Start date: 2005-10-21
    End date: 2005-10-21

Optimark
    Dosage: 19 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-04-20
    End date: 2005-04-20

Omniscan
    Dosage: unk, once
    Start date: 2005-10-01
    End date: 2005-10-01

Omniscan
    Dosage: unk, once
    Start date: 2005-09-06
    End date: 2005-09-06

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-08
    End date: 2005-09-08

Omniscan
    Dosage: unk, once
    Start date: 2005-09-28
    End date: 2005-09-29

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-17
    End date: 2006-03-17

Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Renal
    Start date: 2005-08-25
    End date: 2005-08-25

Omniscan
    Dosage: unk, once
    Indication: Venogram Renal
    Start date: 2005-09-01
    End date: 2005-09-01

Omniscan
    Dosage: unk, once
    Indication: Angiogram Peripheral
    Start date: 2005-08-30
    End date: 2005-08-30

Omniscan
    Dosage: unk, once
    Start date: 2005-11-03
    End date: 2005-11-03

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Start date: 2005-10-03
    End date: 2005-10-03

Omniscan
    Dosage: unk

Optimark
    Dosage: 19 ml, once
    Start date: 2005-07-05
    End date: 2005-07-05

Other drugs received by patient: Cytoxan; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Pentamidine Isethionate; Oxycodone HCL; Wellbutrin; Coumadin; Lopressor; Aspirin; Folic Acid; Flagyl; Acetaminophen; Zaroxolyn; Normodyne; Compazine; Pravachol; Albuterol; Ativan; MS Contin; Fosamax; Thiamine; Calcitriol; Norvasc; Lasix; Darbepoetin Alfa; Heparin; Protonix; Calcitonin Salmon; Labetalol HCL; Renagel; Phoslo; Viagra; Sodium Citrate; Trazodone HCL; Mirapex; Spiriva; Prednisone TAB; Magnesium Oxide; Kayexalate; Lexapro; Lisinopril



Possible Omniscan side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)

Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Arthralgia, Gait Disturbance, Skin Fibrosis, Mobility Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Dosage: 30 ml, once
    Start date: 2000-05-05
    End date: 2000-05-05

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Start date: 2006-07-14
    End date: 2006-07-14

Magnevist
    Dosage: 48 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-02-05
    End date: 2000-02-05

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-12-17
    End date: 2001-12-17

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 39 ml, once
    Start date: 2006-07-26
    End date: 2006-07-26

Unspecified Gadolinium Based Contrast Agent
    Indication: Angiogram
    Start date: 2000-10-01
    End date: 2000-10-15

Magnevist
    Dosage: 40 ml, once
    Start date: 2006-08-09
    End date: 2006-08-09

Other drugs received by patient: Prednisone; Imuran; Norvasc; Calcium Carbonate; Micardis; Oxycet; Darbepoetin Alfa; Minoxidil; Percocet; Renagel; Digoxin; Clonidine; Phoslo; Lanthanum Carbonate; Ferrlecit; Florinef; Lopressor; Plaquenil; Procardia; Zemplar; Coreg; Amiodarone HCL; Aspirin; Cortisone Acetate; Renaphro; Epogen; Vancomycin; Darbepoetin Alfa; Hectorol; Fosrenol



Possible Omniscan side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18

Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)

Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Muscular Weakness, General Physical Health Deterioration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Arthralgia, Gait Disturbance, Mobility Decreased, Skin Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Unspecified Gadolinium Based Contrast Agent
    Indication: Angiogram
    Start date: 2000-10-01
    End date: 2000-10-15

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-12-17
    End date: 2001-12-17

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 48 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-02-05
    End date: 2000-02-05

Magnevist
    Dosage: 39 ml, once
    Start date: 2006-07-26
    End date: 2006-07-26

Magnevist
    Dosage: 30 ml, once
    Start date: 2000-05-05
    End date: 2000-05-05

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Dosage: 40 ml, once
    Start date: 2006-08-09
    End date: 2006-08-09

Unspecified Gadolinium Based Contrast Agent
    Dosage: unk
    Start date: 2006-07-14
    End date: 2006-07-14

Other drugs received by patient: Epogen; Renagel; Procardia; Aspirin; Lopressor; Minoxidil; Ferrlecit; Zemplar; Coreg; Norvasc; Calcium Carbonate; Lanthanum Carbonate; Renaphro; Imuran; Digoxin; Florinef; Cortisone Acetate; Plaquenil; Micardis; Amiodarone HCL; Darbepoetin Alfa; Prednisone; Hectorol; Vancomycin; Darbepoetin Alfa; Phoslo; Fosrenol; Clonidine; Percocet; Oxycet



Possible Omniscan side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-11

Patient: female, weighing 108.8 kg (239.4 pounds)

Reactions: Erythema, Upper Extremity Mass, Joint Stiffness, Muscle Fatigue, Proteinuria, Oedema Peripheral, Renal Cortical Necrosis, Pain in Extremity, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Stress, Emotional Distress, Rash Erythematous, Scar, Soft Tissue Disorder, Pain, Skin Hyperpigmentation, Myosclerosis, Skin Discolouration, Joint Range of Motion Decreased, Oedema, Musculoskeletal Stiffness, Injury, Renal Failure Acute, Musculoskeletal Pain, Rash Papular, Skin Disorder, Renal Failure Chronic, Burning Sensation, Anxiety, Dysstasia, Limb Discomfort, Arthralgia, Renal Tubular Necrosis

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-10-01

Magnevist
    Dosage: daily dose 20 ml
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2007-09-05
    End date: 2007-09-05

Optimark

Multihance

Magnevist
    Dosage: unk
    Start date: 2005-05-26

Omniscan

Magnevist
    Dosage: unk
    Start date: 2004-10-07

Omnipaque 140
    Dosage: 150 ml, unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-09-30
    End date: 2004-09-30

Hypaque-M [meglumine Amidotrizoate]
    Dosage: unk
    Administration route: Oral
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-06
    End date: 2004-10-06

Prohance

Magnevist
    Dosage: unk
    Start date: 2005-05-09

Magnevist
    Dosage: unk
    Start date: 2004-11-18

Magnevist
    Dosage: unk
    Start date: 2005-05-23

Other drugs received by patient: Cytoxan; Xanax; Sensipar; Ferrous Sulfate TAB; Contrast Media; Immune Globulin NOS; Gabapentin; Valcyte; Contrast Media; Prednisone; Lasix; Marijuana; Midodrine Hydrochloride; Lisinopril; Aspirin; Norvasc; Cyclobenzaprine; Calcium +vit D; Coumadin; Contrast Media; Lopressor; Epogen; Cellcept; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Gengraf; Renagel



Possible Omniscan side effects in 31 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10

Patient: 31 year old female, weighing 59.8 kg (131.6 pounds)

Reactions: Pruritus, Pain, Joint Contracture, Skin Burning Sensation, Muscle Spasticity, Joint Stiffness, Myalgia, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Skin Swelling, Pain in Extremity, Muscle Contracture, Muscular Weakness, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Stress, Skin Tightness, Finger Deformity, Anxiety, Arthralgia, Exfoliative Rash, Gait Disturbance, Atrophy

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Multihance
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk
    Indication: Angiogram
    Start date: 2003-01-10
    End date: 2003-01-10

Prohance
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging Brain

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2007-01-18
    End date: 2007-01-18

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-22
    End date: 2003-09-22

Other drugs received by patient: Amlodipine Besylate; Accupril; Ibuprofen; Renagel; Cardura; Depakote; Amiodarone HCL; Elavil; Pravastatin; Labetalol HCL; Phenytoin; Aspirin; Metoprolol Tartrate; Morphine; Plendil; Lovenox; Methadone HCL; Lidocaine; Vitamin K TAB; Clonidine; Heparin; Lamictal; Folic Acid; Enoxaparin; Promethazine; Norvasc; Cardizem; Coumadin; Prednisone TAB; Diazepam; Dilantin; Vicodin; Xanax



Possible Omniscan side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10

Patient: 62 year old male, weighing 124.0 kg (272.8 pounds)

Reactions: Hyperkeratosis, Pruritus, Pain, Erythema, Rash Pruritic, Skin Ulcer, Oedema Peripheral, Skin Lesion, Skin Atrophy, Pain in Extremity, Pain of Skin, Skin Disorder, Skin Hypertrophy, DRY Skin, Hypoaesthesia, Skin Induration, Rash, Nephrogenic Systemic Fibrosis, Skin Plaque, Emotional Distress, Burning Sensation, Anxiety, Exfoliative Rash, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-01-17
    End date: 2006-01-17

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: 40 ml, then 50 ml
    Indication: Angiogram
    Start date: 2004-11-09
    End date: 2004-11-09

Other drugs received by patient: Norvasc; Folic Acid; Hydrochlorothiazide; Dalteparin Sodium; Hydralazine HCL; Calcium; Epogen; Gabapentin; Furosemide; Darvocet; Renagel; Carvedilol; Benicar; Simvastatin; Lyrica; Magnesium; Renagel; Aranesp; Metoprolol Tartrate; Doxazosin Mesylate; Atenolol; Mirtazapine; Codeine SUL TAB



Possible Omniscan side effects in 82 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08

Patient: 82 year old female, weighing 69.8 kg (153.7 pounds)

Reactions: Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hyperpigmentation, Hypoaesthesia, Deformity, Muscle Tightness, Skin Tightness, Skin Plaque, Pruritus Generalised, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Prohance
    Indication: Diagnostic Procedure

Magnevist
    Indication: Diagnostic Procedure

Optimark
    Indication: Diagnostic Procedure

Multihance
    Indication: Diagnostic Procedure

Omniscan
    Indication: Diagnostic Procedure

Contrast Media
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Xalatan; Multivitamins and Iron; Colchicine; Aspirin; Lotrel; Meloxicam; Alphagan; Cosopt; Plavix; Hydrochlorothiazide; Cyproheptadine HCL; Amlodipine Besylate and Benazepril HCL; Lovenox



Possible Omniscan side effects in 82 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08

Patient: 82 year old female, weighing 69.8 kg (153.7 pounds)

Reactions: Pain, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Induration, Hypoaesthesia, Skin Hyperpigmentation, Deformity, Muscle Tightness, Skin Tightness, Skin Plaque, Pruritus Generalised, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Magnevist
    Indication: Diagnostic Procedure

Multihance
    Indication: Diagnostic Procedure

Contrast Media
    Indication: Product Used FOR Unknown Indication

Optimark
    Indication: Diagnostic Procedure

Omniscan
    Indication: Diagnostic Procedure

Prohance
    Indication: Diagnostic Procedure

Other drugs received by patient: Plavix; Hydrochlorothiazide; Xalatan; Meloxicam; Colchicine; Aspirin; Lovenox; Cosopt; Alphagan; Multivitamins and Iron; Cyproheptadine HCL; Amlodipine Besylate and Benazepril HCL; Lotrel



Possible Omniscan side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-07

Patient: female

Reactions: Pain, Skin Hyperpigmentation, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Muscle Tightness, Joint Range of Motion Decreased, Oedema Peripheral, Ocular Icterus, Extremity Contracture, Scleral Disorder

Drug(s) suspected as cause:
Omniscan
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-07-20

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Magnevist

Prohance
    Indication: Angiogram

Other drugs received by patient: Labetalol HCL; Coumadin; Zocor



Possible Omniscan side effects in 52 year old female

Reported by a consumer/non-health professional from United States on 2012-05-04

Patient: 52 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Soft Tissue Disorder, Joint Contracture, Abasia, Pain, Skin Hyperpigmentation, Muscle Fibrosis, Joint Stiffness, Myosclerosis, Calcification of Muscle, Skin Discolouration, Impaired Self-Care, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Unevaluable Event, Extremity Contracture, Skin Disorder, Skin Hypopigmentation, Nephrogenic Systemic Fibrosis, Skin Induration, Stress, Amnesia, Skin Plaque, Anxiety, Dysphonia, Skin Fibrosis, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Omniscan
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1998-06-01
    End date: 1998-06-01

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Thoracic
    Start date: 1999-05-14
    End date: 1999-05-14

Omniscan
    Dosage: unk, once
    Indication: Angiogram
    Start date: 2001-07-20
    End date: 2001-07-20

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Thoracic
    Start date: 2003-09-09
    End date: 2003-09-09

Omniscan
    Dosage: 0.15 mmol/kg
    Start date: 2000-04-18
    End date: 2000-04-18

Omniscan
    Dosage: 30 ml, once
    Indication: Venogram
    Start date: 2000-10-19
    End date: 2000-10-19

Omniscan
    Dosage: 0.1 mmol/kg, unk
    Start date: 2003-10-20
    End date: 2003-10-20

Omniscan
    Dosage: 40 ml, once
    Start date: 2001-10-16
    End date: 2001-10-16

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 1998-06-01
    End date: 1998-06-01

Magnevist
    Dosage: unk
    Start date: 2003-09-25
    End date: 2003-09-25

Omniscan
    Dosage: 50 ml, once
    Start date: 2003-09-30
    End date: 2003-09-30

Magnevist
    Indication: Angiogram

Omniscan
    Dosage: daily dose 40 ml
    Start date: 2002-11-01
    End date: 2002-11-01

Omniscan
    Dosage: 0.2mmol/kg
    Start date: 2003-09-27
    End date: 2003-09-27

Omniscan
    Dosage: 0.1mmol/kg
    Start date: 2003-10-03
    End date: 2003-10-03

Other drugs received by patient: Simvastatin; Coumadin; Avapro; Maxidex; Claforan; Omnipaque 140; Metoprolol Tartrate; Enalapril Maleate; Chlorothiazide; Furosemide; Moduretic 5-50; Cozaar; Lasix; Magnesium Oxide; Potassium Chloride; Benadryl; Nifedipine; Sevelamer; Potassium Chloride; Spironolactone; Epogen; Iron Supplement; Omnipaque 140; Clonidine; Flonase



Possible Omniscan side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03

Patient: 57 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Erythema, Joint Stiffness, Anhedonia, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Skin Lesion, Musculoskeletal Stiffness, Injury, Peau D'orange, Pain in Extremity, Muscular Weakness, Hypoaesthesia, DRY Skin, Skin Hypertrophy, Skin Hypopigmentation, Nephrogenic Systemic Fibrosis, Skin Plaque, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Omniscan
    Dosage: unk, once
    Indication: Venogram Renal
    Start date: 2005-09-01
    End date: 2005-09-01

Omniscan
    Dosage: unk, once
    Start date: 2005-09-28
    End date: 2005-09-29

Omniscan
    Dosage: unk, once
    Start date: 2005-11-03
    End date: 2005-11-03

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk unk, once
    Indication: Renal Scan
    Start date: 2005-08-25
    End date: 2005-08-25

Optimark
    Dosage: 19 ml, once
    Start date: 2005-07-05
    End date: 2005-07-05

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-08
    End date: 2005-09-08

Omniscan
    Dosage: unk, once
    Start date: 2005-10-01
    End date: 2005-10-01

Omniscan
    Dosage: unk, once
    Start date: 2005-10-18
    End date: 2005-10-18

Optimark
    Dosage: 19 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-04-20
    End date: 2005-04-20

Omniscan
    Dosage: unk, once
    Indication: Angiogram Peripheral
    Start date: 2005-08-30
    End date: 2005-08-30

Omniscan
    Dosage: unk

Omniscan
    Dosage: unk, once
    Start date: 2005-10-03
    End date: 2005-10-03

Omniscan
    Dosage: unk, once
    Start date: 2005-10-21
    End date: 2005-10-21

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Gadolinium IN Unspecified Drug
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-03-17
    End date: 2006-03-17

Omniscan
    Dosage: unk, once
    Start date: 2005-09-06
    End date: 2005-09-06

Other drugs received by patient: Pravachol; Sodium Citrate; Kayexalate; Oxycodone HCL; Aspirin; Prednisone; Calcitonin Salmon; Zaroxolyn; MS Contin; Lexapro; Lisinopril; Coumadin; Pentamidine; Compazine; Spiriva; Ativan; Norvasc; Lasix; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Flagyl; Calcitriol; Labetalol HCL; Phoslo; Normodyne; Lopressor; Thiamine; Cytoxan; Wellbutrin; Viagra; Heparin; Trazodone HCL; Protonix; Darbepoetin Alfa; Fosamax; Folic Acid; Albuterol; Acetaminophen; Magnesium Oxide; Mirapex



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012